Publications

Found 13 results
Author Title [ Type(Desc)] Year
Filters: Author is Ishii, Makoto  [Clear All Filters]
Journal Article
Ishii M, Iadecola C.  2016.  Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology.. Biochim Biophys Acta. 1862(5):966-74.
Ishii M, Hiller AJ, Pham L, McGuire MJ, Iadecola C, Wang G.  2019.  Amyloid-beta modulates low-threshold activated voltage-gated L-type calcium channels of arcuate neuropeptide Y neurons leading to calcium dysregulation and hypothalamic dysfunction.. J Neurosci.
Ishii M.  2019.  Apolipoprotein B as a New Link Between Cholesterol and Alzheimer Disease.. JAMA Neurol.
Hiller AJ, Ishii M.  2018.  Disorders of Body Weight, Sleep and Circadian Rhythm as Manifestations of Hypothalamic Dysfunction in Alzheimer's Disease.. Front Cell Neurosci. 12:471.
McGuire MJ, Ishii M.  2016.  Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies.. Cell Mol Neurobiol. 36(2):203-17.
Ishii M, Iadecola C.  2015.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.. Cell Metab. 22(5):761-76.
Ishii M.  2021.  Midlife dyslipidaemia as a modifiable risk factor for later-life dementia.. Lancet Healthy Longev. 2(8):e453-e454.
Ishii M, Iadecola C.  2020.  A Novel Neurovascular Liaison Governing the Blood-Brain Barrier.. Neuron. 107(2):205-207.
Eruysal E, Ravdin L, Kamel H, Iadecola C, Ishii M.  2019.  Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease.. Alzheimers Dement (Amst). 11:646-653.
Ishii M, Kamel H, Iadecola C.  2018.  Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia.. J Alzheimers Dis.
Ishii M.  2016.  The Role of the Adipocyte Hormone Leptin in Alzheimer's Disease.. Keio J Med. 65(1):21.
Eruysal E, Ravdin L, Zhang C, Kamel H, Iadecola C, Ishii M.  2023.  Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.. J Alzheimers Dis. 91(3):1073-1083.
Ishii M, Wang G, Racchumi G, Dyke JP, Iadecola C.  2014.  Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons.. J Neurosci. 34(27):9096-106.